Kadlec Regional Medical Center is now providing the WATCHMAN device, a heart implant designed to prevent strokes in people with atrial fibrillation (AFib) not linked to heart ...

VERITAS involved 400 patients at 34 sites across Europe, Canada, and the US.

Johnson & Johnson JNJ on Friday after hours released data from the OMNY-AF pilot study, a prospective, single-arm, ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of the ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a 70-year old woman with a prior history of ...

CHICAGO (Reuters) - Johnson & Johnson's ablation device outperformed drug therapy for the heart rhythm disorder atrial fibrillation in a study that will be used to seek U.S. regulatory approval for ...

For patients with Afib, using a wearable device can lead to higher rates of anxiety about their Afib symptoms and treatment, doctor visits, and use of informal healthcare resources, according to a new ...

Asymptomatic AFib is a silent condition, so it often goes undetected until a routine physical, smart technology alert, or a ...

Abbott Laboratories' second-generation pulse field ablation device for atrial fibrillation has received European CE Mark approval earlier than expected, the North Chicago-based company said today. The ...

Dear Dr. Roach: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I've been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...